Sign In To Continue
You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
A US jury has ruled that Amgen must pay $20.2 million in damages for infringing an antibody patent. The verdict underscores ongoing patent enforcement challenges in the biopharmaceutical sector, highlighting the high stakes involved in antibody-related intellectual property disputes.
Share This Article
Ready-to-post copy includes the article link.
US Jury Orders Amgen to Pay $20.2 Million in Antibody Patent Infringement Case A US jury has ruled that Amgen must pay $20.2 million in damages for infringing an antibody patent. The verdict underscores ongoing patent enforcement challenges in the biopharmaceutical sector, highlighting the high st... Read the full IIPLA article: https://iipla.org/news/us-jury-orders-amgen-to-pay-20-2-million-in-antibody-patent-infringement-case